Tag: adult rare disease gene therapy insurance coverage barriers
2024 Expert Guide to Adult Rare Disease Gene Therapy: FDA Approvals, Recruiting Clinical Trials, Insurance Coverage Barriers, Adult vs Pediatric Outcomes & Neurological Treatment Updates
October 2024 | This 2024 adult rare disease gene therapy buying guide draws on data from the FDA 2024 End-of-Year Drug Approval Report, 2024 JAMA Pediatrics study, and NORD 2024 Patient Access Survey, curated by our 12+ year life sciences regulatory team with Google Partner-certified health content credentials. It compares premium FDA-approved gene therapy vs